Market-Moving News for September 15th
Portfolio Pulse from ryanfaloona@benzinga.com
The FDA has updated the PDUFA action date for IOVA's Lifileucel, causing a 24% increase in IOVA's stock. B of A Securities has upgraded Unity Software to 'Buy' and raised its price target to $56, resulting in a 3% increase in Unity's stock. ASML's shares have dropped by 3% after TSMC reportedly asked its suppliers to delay the delivery of high-end chipmaking equipment.
September 15, 2023 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ASML's shares have dropped by 3% after TSMC reportedly asked its suppliers to delay the delivery of high-end chipmaking equipment.
TSMC's request for a delay in equipment delivery could indicate a slowdown in demand, which is likely viewed negatively by investors, leading to the drop in ASML's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
The FDA's update of the PDUFA action date for Lifileucel has led to a 24% increase in IOVA's stock.
The FDA's update is a positive development for IOVA, indicating progress in the approval process for Lifileucel. This has likely boosted investor confidence, leading to the stock price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
B of A Securities' upgrade of Unity Software to 'Buy' and price target increase to $56 has led to a 3% increase in Unity's stock.
The upgrade and price target increase by B of A Securities is a positive endorsement for Unity Software, likely leading to increased investor interest and the subsequent stock price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100